Atjaunināt sīkdatņu piekrišanu

E-grāmata: Heme Oxygenase: Clinical Applications and Functions

  • Formāts: 288 pages
  • Izdošanas datums: 20-Dec-2024
  • Izdevniecība: CRC Press Inc
  • Valoda: eng
  • ISBN-13: 9781040281567
Citas grāmatas par šo tēmu:
  • Formāts - EPUB+DRM
  • Cena: 375,69 €*
  • * ši ir gala cena, t.i., netiek piemērotas nekādas papildus atlaides
  • Ielikt grozā
  • Pievienot vēlmju sarakstam
  • Šī e-grāmata paredzēta tikai personīgai lietošanai. E-grāmatas nav iespējams atgriezt un nauda par iegādātajām e-grāmatām netiek atmaksāta.
  • Bibliotēkām
Heme Oxygenase: Clinical Applications and FunctionsPalielināt
  • Formāts: 288 pages
  • Izdošanas datums: 20-Dec-2024
  • Izdevniecība: CRC Press Inc
  • Valoda: eng
  • ISBN-13: 9781040281567
Citas grāmatas par šo tēmu:

DRM restrictions

  • Kopēšana (kopēt/ievietot):

    nav atļauts

  • Drukāšana:

    nav atļauts

  • Lietošana:

    Digitālo tiesību pārvaldība (Digital Rights Management (DRM))
    Izdevējs ir piegādājis šo grāmatu šifrētā veidā, kas nozīmē, ka jums ir jāinstalē bezmaksas programmatūra, lai to atbloķētu un lasītu. Lai lasītu šo e-grāmatu, jums ir jāizveido Adobe ID. Vairāk informācijas šeit. E-grāmatu var lasīt un lejupielādēt līdz 6 ierīcēm (vienam lietotājam ar vienu un to pašu Adobe ID).

    Nepieciešamā programmatūra
    Lai lasītu šo e-grāmatu mobilajā ierīcē (tālrunī vai planšetdatorā), jums būs jāinstalē šī bezmaksas lietotne: PocketBook Reader (iOS / Android)

    Lai lejupielādētu un lasītu šo e-grāmatu datorā vai Mac datorā, jums ir nepieciešamid Adobe Digital Editions (šī ir bezmaksas lietotne, kas īpaši izstrādāta e-grāmatām. Tā nav tas pats, kas Adobe Reader, kas, iespējams, jau ir jūsu datorā.)

    Jūs nevarat lasīt šo e-grāmatu, izmantojot Amazon Kindle.

A comprehensive account of the biochemical, toxicological, molecular, and clinical aspects of heme oxygenase, an enzyme that is important because of its function as the initial and rate-limited step in the degradation of the heme molecule. Includes an introduction to the pathway of heme metabolism, and accounts of such recent discoveries as that one of the two isozymes is a heat shock/stress protein, that bile pigments are potent antioxidants, and that synthetic metalloporphyrins control heme oxygenase activity, and hence suppress neonatal hyperbilirubinemia. A historical review traces the development of understanding since the enzyme was first described in 1968. Annotation copyright Book News, Inc. Portland, Or.

his book provides a comprehensive summary of data from basic research on characterization, regulation, and function of heme oxygenase in mammalian systems. The book also includes a major section that covers the currently used clinical methods to suppress neonatal jaundice with emphasis on the newly developed use of synthetic metalloporophyrins. This book will be welcomed by researchers and students in pharmacology, biochemistry, pharmacy, neonatology, hematology, internal medicine, and endocrinology.
AN OVERVIEW OF PORPHYRINS AND HEMES AND THEIR BIOSYNTHETIC PATHWAY. Introduction. Porphyrins and Metalloporphyrins-General Properties. d-Aminolevulinate Synthetase. d-Aminolevulinate Dehydratase. Porphobilinogen Deaminase and Uroporphyrinogen III Synthetase. Uroporphyrinogen III Decarboxylase. Coproporphyrinogen Oxidase. Protoporphyrin Oxidase. Ferrochelatase. Disorders of Porphyrin Metabolism (Porphyrias). References. BILIVERDIN REDUCTASE. Introduction. References. HEME OXYGENASE AND HEME DEGRADING SYSTEMS. Introduction. Nonenzymatic Degradation of Heme by Heme Oxygenase. Enzymatic Degradation of Heme by Heme Oxygenase. References. CHARACTERIZATION AND REGULATION OF HEME OXYGENASE ISOZYMES AT THE MOLECULAR LEVEL. Background. Molecular and Biochemical Properties of Heme Oxygenase Isozymes. Molecular Cloning and Characterization of HO-1 and HO-2. References. REGULATION OF HEME OXYGENASE ACTIVITY. RESULTANT MODULATING EFFECT ON HEMOPROTEIN-DEPENDENT FUNCTIONS. Introduction. Mechanisms of Heme Oxygenase Regulation. Consequences of Induction of Heme Oxygenase on Drug Steroid and Prostaglandin Metabolic Systems. References. NEONATAL JAUNDICE. Introduction: Jaundice in the Newborn. Factors Influencing Serum Bilirubin Levels in the Newborn. Toxicity of Bilirubin to the Newborn. Developmental Changes in Cellular Ability to Produce Bilirubin in the Newborn. Possible Physiological Importance of Bilirubin. Treatment of Hyperbilirubinemia. References.
Mahin D. Maines
Biežāk uzdotie jautājumi par e-grāmatām Biežāk uzdotie jautājumi par e-grāmatām
Permanent link: https://www.kriso.lv/db/97810402815676e.html
Keywords: